Clinical research on sequential combination therapy with CHOP and mogamulizumab in patients with untreated primary adult T cell leukemia-lymphoma (FBMTG MOG16)
Latest Information Update: 27 Jan 2022
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Mogamulizumab (Primary) ; Prednisone (Primary) ; Prednisone (Primary) ; Vincristine (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms FBMTG MOG16
- 14 Dec 2021 Results (n=24) presented at the 63rd American Society of Hematology Annual Meeting and Exposition.
- 06 Jan 2017 Status changed from not yet recruiting to recruiting.
- 28 Jun 2016 New trial record